CONTEXT: Female sexual pain and dysfunction. OBJECTIVE: To evaluate the effectiveness of a new site-specific, manual soft-tissue therapy in increasing orgasm and reducing dyspareunia (painful intercourse) in women with histories indicating abdominopelvic adhesion formation. DESIGN AND INTERVENTION: A total of 29 new patients presenting with infertility or abdominopelvic pain-related problems, and also indicating sexual pain or dysfunction, received a series of treatments (mean, 19.5 hours) designed to address biomechanical dysfunction and restricted mobility due to adhesions affecting the reproductive organs and adjacent structures. OUTCOME MEASURES: Primary outcome measures were post-test vs pretest scores on: (1) the Female Sexual Function Index (FSFI) full scale, orgasm domain, and pain domain; and (2) 3 supplemental 10-point rating scales of sexual pain levels. Secondary outcome measures were post-test vs pretest scores in the other 4 FSFI domains (desire, arousal, lubrication, and satisfaction). The Wilcoxon signed-rank test was used for all statistical analyses. RESULTS: For the 23 patients available for follow-up, the paired FSFI post-test vs pretest scores were significant (P < or = .003) on all measures. Of the 17 patients who completed the 3 sexual pain scales, the paired post-test vs pretest scores were significant (P < or = .002). CONCLUSIONS: Many cases of inhibited orgasm, dyspareunia, and other aspects of sexual dysfunction seem to be treatable by a distinctive, noninvasive manual therapy with no risks and few, if any, adverse effects. The therapy should be considered a new adjunct to existing gynecologic and medical treatments.
CONTEXT: Female sexual pain and dysfunction. OBJECTIVE: To evaluate the effectiveness of a new site-specific, manual soft-tissue therapy in increasing orgasm and reducing dyspareunia (painful intercourse) in women with histories indicating abdominopelvic adhesion formation. DESIGN AND INTERVENTION: A total of 29 new patients presenting with infertility or abdominopelvic pain-related problems, and also indicating sexual pain or dysfunction, received a series of treatments (mean, 19.5 hours) designed to address biomechanical dysfunction and restricted mobility due to adhesions affecting the reproductive organs and adjacent structures. OUTCOME MEASURES: Primary outcome measures were post-test vs pretest scores on: (1) the Female Sexual Function Index (FSFI) full scale, orgasm domain, and pain domain; and (2) 3 supplemental 10-point rating scales of sexual pain levels. Secondary outcome measures were post-test vs pretest scores in the other 4 FSFI domains (desire, arousal, lubrication, and satisfaction). The Wilcoxon signed-rank test was used for all statistical analyses. RESULTS: For the 23 patients available for follow-up, the paired FSFI post-test vs pretest scores were significant (P < or = .003) on all measures. Of the 17 patients who completed the 3 sexual pain scales, the paired post-test vs pretest scores were significant (P < or = .002). CONCLUSIONS: Many cases of inhibited orgasm, dyspareunia, and other aspects of sexual dysfunction seem to be treatable by a distinctive, noninvasive manual therapy with no risks and few, if any, adverse effects. The therapy should be considered a new adjunct to existing gynecologic and medical treatments.
Authors: R Basson; J Berman; A Burnett; L Derogatis; D Ferguson; J Fourcroy; I Goldstein; A Graziottin; J Heiman; E Laan; S Leiblum; H Padma-Nathan; R Rosen; K Segraves; R T Segraves; R Shabsigh; M Sipski; G Wagner; B Whipple Journal: J Urol Date: 2000-03 Impact factor: 7.450
Authors: Belinda F Wurn; Lawrence J Wurn; C Richard King; Marvin A Heuer; Amanda S Roscow; Eugenia S Scharf; Jonathan J Shuster Journal: MedGenMed Date: 2004-06-18
Authors: Amanda D Rice; Leslie B Wakefield; Kimberley Patterson; Evette D'Avy Reed; Belinda F Wurn; C Richard King; Lawrence J Wurn Journal: Pediatr Rep Date: 2014-02-24
Authors: Amanda D Rice; Kimberley Patterson; Evette D Reed; Belinda F Wurn; Bernhard Klingenberg; C Richard King; Lawrence J Wurn Journal: Biomed Res Int Date: 2016-02-18 Impact factor: 3.411
Authors: Amanda D Rice; Kimberley Patterson; Evette D Reed; Belinda F Wurn; Kristen Robles; Bernhard Klingenberg; Leonard B Weinstock; Janey Sa Pratt; C Richard King; Lawrence J Wurn Journal: World J Gastroenterol Date: 2018-05-21 Impact factor: 5.742